These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35191167)

  • 1. Successful deceased donor liver transplantation in candidates with high MELD and ongoing positive SARS-CoV-2 PCR.
    Vissichelli NC; Morales MK; Bryson A; Bruno D
    Transpl Infect Dis; 2022 Apr; 24(2):e13816. PubMed ID: 35191167
    [No Abstract]   [Full Text] [Related]  

  • 2. Utilization and outcomes of deceased donor SARS-CoV-2-positive organs for solid organ transplantation in the United States.
    Schold JD; Koval CE; Wee A; Eltemamy M; Poggio ED
    Am J Transplant; 2022 Sep; 22(9):2217-2227. PubMed ID: 35730252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women Are Disadvantaged During Deceased Donor Liver Transplant Allocation: Strategies to Overcome Inequities.
    Kefalakes H
    Gastroenterology; 2022 Jun; 162(7):2110-2111. PubMed ID: 35346649
    [No Abstract]   [Full Text] [Related]  

  • 4. Pediatric Living Donor Liver Transplantation: Optimizing Outcomes for Recipients, Donors, and the Waiting List.
    Duggan EM; Griesemer AD
    Liver Transpl; 2022 Mar; 28(3):359-360. PubMed ID: 34822221
    [No Abstract]   [Full Text] [Related]  

  • 5. The Effect of Acuity Circles on Deceased Donor Transplant and Offer Rates Across Model for End-Stage Liver Disease Scores and Exception Statuses.
    Wey A; Noreen S; Gentry S; Cafarella M; Trotter J; Salkowski N; Segev D; Israni A; Kasiske B; Hirose R; Snyder J
    Liver Transpl; 2022 Mar; 28(3):363-375. PubMed ID: 34482614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ recovery from deceased donors with prior COVID-19: A case series.
    Neidlinger NA; Smith JA; D'Alessandro AM; Roe D; Taber TE; Pereira MR; Friedman AL
    Transpl Infect Dis; 2021 Apr; 23(2):e13503. PubMed ID: 33174324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deceased Donor Liver Transplantation from a SARS-CoV-2-Positive Donor to a SARS-CoV-2-Positive Recipient.
    Barros N; Ermel A; Mihaylov P; Lacerda M; Fridell J; Kubal C
    Liver Transpl; 2021 Dec; 27(12):1849-1851. PubMed ID: 34351679
    [No Abstract]   [Full Text] [Related]  

  • 8. MELD-based liver allocation: who is underserved?
    Biggins SW; Bambha K
    Semin Liver Dis; 2006 Aug; 26(3):211-20. PubMed ID: 16850370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor.
    Manzia TM; Gazia C; Lenci I; Angelico R; Toti L; Monaco A; Anselmo A; Baiocchi L; Grossi P; Tisone G
    Am J Transplant; 2021 Jul; 21(7):2600-2604. PubMed ID: 33621393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current trends in living donor liver transplantation for primary sclerosing cholangitis.
    Goldberg DS; French B; Thomasson A; Reddy KR; Halpern SD
    Transplantation; 2011 May; 91(10):1148-52. PubMed ID: 21544035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.
    Sharma P; Schaubel DE; Messersmith EE; Guidinger MK; Merion RM
    Liver Transpl; 2012 Dec; 18(12):1456-63. PubMed ID: 22965903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a deceased donor liver allograft from a COVID-positive donor.
    Rosenzweig M; Finotti M; Martinez E; Testa G
    Am J Transplant; 2022 Jun; 22(6):1721-1723. PubMed ID: 35674155
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
    Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS
    Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplant recipient selection: MELD vs. clinical judgment.
    Fink MA; Angus PW; Gow PJ; Berry SR; Wang BZ; Muralidharan V; Christophi C; Jones RM
    Liver Transpl; 2005 Jun; 11(6):621-6. PubMed ID: 15915491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful transplantation of organs from a deceased donor with early SARS-CoV-2 infection.
    Dhand A; Gass A; Nishida S; Kai M; Berger K; Wolf D; Ohira S; Sogawa H; Lee L; Lebovics E; Ezzell C; Diflo T; Spielvogel D; Latifi R; Friedman AL
    Am J Transplant; 2021 Nov; 21(11):3804-3805. PubMed ID: 34058068
    [No Abstract]   [Full Text] [Related]  

  • 18. MELD-based allocation of deceased donor livers: is equality possible?
    Neuberger J
    Transpl Int; 2016 Aug; 29(8):880-2. PubMed ID: 27160971
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of COVID - 19 in patients awaiting liver transplantation.
    Kounis I; Duhaut L; Breard T; Samuel D; Coilly A
    Liver Int; 2022 Jan; 42(1):256-257. PubMed ID: 34797949
    [No Abstract]   [Full Text] [Related]  

  • 20. Stable and safe organ procurement and transplantation during SARS-CoV-2 pandemic in Germany.
    Hugo C; Strassburg C; Stecher M; Rahmel A
    Transpl Int; 2020 Oct; 33(10):1335-1336. PubMed ID: 32697364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.